Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1948)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$494.33
Total Value
$257.05K
Shares Held After
327,403
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$493.59
Total Value
$256.67K
Shares Held After
327,923
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,067
Price
$492.25
Total Value
$1.02M
Shares Held After
328,443
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,833
Price
$491.38
Total Value
$900.70K
Shares Held After
330,510
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$490.19
Total Value
$274.51K
Shares Held After
332,343
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$489.06
Total Value
$117.37K
Shares Held After
332,903
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$486.32
Total Value
$77.81K
Shares Held After
333,143
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$485.12
Total Value
$58.21K
Shares Held After
333,303
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$482.61
Total Value
$38.61K
Shares Held After
333,423
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$479.89
Total Value
$76.78K
Shares Held After
333,503
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$478.85
Total Value
$76.62K
Shares Held After
333,663
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$477.70
Total Value
$57.32K
Shares Held After
333,823
% of Holdings
0.0%
Hims&Hers Health, Inc. (HIMS)
Boughton Soleil — Chief Legal Officer
Shares
3,458
Price
$28.33
Total Value
$97.97K
Shares Held After
310,506
% of Holdings
1.1%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
900
Price
$68.95
Total Value
$62.05K
Shares Held After
526,900
% of Holdings
0.2%
Teladoc Health, Inc. (TDOC)
DIVITA CHARLES III — Director
Shares
18,327
Price
$6.30
Total Value
$115.48K
Shares Held After
440,538
% of Holdings
4.0%
Teladoc Health, Inc. (TDOC)
Vandervoort Adam C — CHIEF LEGAL OFFICER, SECRETARY
Shares
7,573
Price
$6.30
Total Value
$47.72K
Shares Held After
117,616
% of Holdings
6.0%
Teladoc Health, Inc. (TDOC)
Catapano Joseph Ronald — Chief Accounting Officer
Shares
274
Price
$6.30
Total Value
$1.73K
Shares Held After
12,865
% of Holdings
2.1%
Teladoc Health, Inc. (TDOC)
Bliss Kelly — President, U.S. Group Health
Shares
7,357
Price
$6.30
Total Value
$46.36K
Shares Held After
92,832
% of Holdings
7.3%
Teladoc Health, Inc. (TDOC)
Nueno Carlos — President, International
Shares
6,200
Price
$6.30
Total Value
$39.07K
Shares Held After
64,744
% of Holdings
8.7%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
642
Price
$66.37
Total Value
$42.61K
Shares Held After
118,016
% of Holdings
0.5%
APTARGROUP, INC. (ATR)
Vinczeller Shiela — Chief Human Resources Officer
Shares
765
Price
$130.37
Total Value
$99.73K
Shares Held After
26,313
% of Holdings
2.8%
RxSight, Inc. (RXST)
Weinberg Eric — Chief Business Development Officer
Shares
2,041
Price
$6.96
Total Value
$14.21K
Shares Held After
200,348
% of Holdings
1.0%
RxSight, Inc. (RXST)
Kurtz Ronald M MD — Chief Medical Officer
Shares
5,100
Price
$6.96
Total Value
$35.50K
Shares Held After
71,775
% of Holdings
6.6%
RxSight, Inc. (RXST)
Goldshleger Ilya — Chief Operating Officer
Shares
2,041
Price
$6.96
Total Value
$14.21K
Shares Held After
81,509
% of Holdings
2.4%
RxSight, Inc. (RXST)
Wilterding Mark — Chief Financial Officer
Shares
7,765
Price
$6.96
Total Value
$54.04K
Shares Held After
25,049
% of Holdings
23.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
400
Price
$26.64
Total Value
$10.65K
Shares Held After
9,110
% of Holdings
4.2%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
5,387
Price
$25.69
Total Value
$138.42K
Shares Held After
9,510
% of Holdings
36.2%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
187,704
Price
$1.80
Total Value
$337.59K
Shares Held After
5,624,151
% of Holdings
3.3%
Shares
3,000
Price
$0.05
Total Value
$146.70
Shares Held After
9,387,256
% of Holdings
0.0%
Perspective Therapeutics, Inc. (CATX)
Lantheus Alpha Therapy, LLC — 10% Owner
Shares
35,769
Price
$3.12
Total Value
$111.57K
Shares Held After
11,563,425
% of Holdings
0.3%
AN2 Therapeutics, Inc. (ANTX)
Williams Sarah Joanne — Principal Accounting Officer
Shares
272
Price
$5.53
Total Value
$1.50K
Shares Held After
66,311
% of Holdings
0.4%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
4,601
Price
$73.86
Total Value
$339.83K
Shares Held After
18,707
% of Holdings
19.7%
Tempus AI, Inc. (TEM)
Doudna Jennifer A — Director
Shares
676
Price
$65.55
Total Value
$44.31K
Shares Held After
25,266
% of Holdings
2.6%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
31,908
Price
$26.29
Total Value
$838.78K
Shares Held After
223,355
% of Holdings
12.5%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
2,593
Price
$26.31
Total Value
$68.21K
Shares Held After
18,151
% of Holdings
12.5%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
1
Price
$79.95
Total Value
$79.95
Shares Held After
14,012
% of Holdings
0.0%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
58
Price
$79.95
Total Value
$4.64K
Shares Held After
337,427
% of Holdings
0.0%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
70
Price
$79.95
Total Value
$5.60K
Shares Held After
349,140
% of Holdings
0.0%
CASTLE BIOSCIENCES INC (CSTL)
Oelschlager Kristen M — Chief Operating Officer
Shares
200
Price
$34.02
Total Value
$6.80K
Shares Held After
13,356
% of Holdings
1.5%
CASTLE BIOSCIENCES INC (CSTL)
Oelschlager Kristen M — Chief Operating Officer
Shares
3,952
Price
$33.36
Total Value
$131.84K
Shares Held After
13,556
% of Holdings
22.6%
Tempus AI, Inc. (TEM)
Epstein David R — Director
Shares
250
Price
$65.55
Total Value
$16.39K
Shares Held After
30,844
% of Holdings
0.8%
VERACYTE, INC. (VCYT)
Bhanji Muna — Director
Shares
1,864
Price
$42.97
Total Value
$80.10K
Shares Held After
42,718
% of Holdings
4.2%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — See Remarks
Shares
400
Price
$89.38
Total Value
$35.75K
Shares Held After
2,845
% of Holdings
12.3%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — See Remarks
Shares
6,206
Price
$88.17
Total Value
$547.18K
Shares Held After
3,245
% of Holdings
65.7%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — See Remarks
Shares
16,548
Price
$87.20
Total Value
$1.44M
Shares Held After
9,451
% of Holdings
63.6%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — See Remarks
Shares
4,845
Price
$86.40
Total Value
$418.61K
Shares Held After
25,999
% of Holdings
15.7%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
2,281
Price
$115.61
Total Value
$263.71K
Shares Held After
9,755
% of Holdings
19.0%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
10,989
Price
$114.71
Total Value
$1.26M
Shares Held After
12,036
% of Holdings
47.7%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
11,730
Price
$113.94
Total Value
$1.34M
Shares Held After
23,025
% of Holdings
33.8%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
600
Price
$321.91
Total Value
$193.14K
Shares Held After
126,019
% of Holdings
0.5%
Showing 201–250 of 1948 transactions (page 5 of 39)